Hepatoprotective Effects of Imeglimin Are Associated With Preserved Mitochondrial Bioenergetics and Reduced Oxidative Stress in a Murine Cholestasis Model.

IF 3.7 3区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY
Hiroki Goto, Kazuto Suda, Takehiro Yasukawa, Takashi Fujimoto, Xuxuan Rao, Yosuke Tsunoda, Masataka Hida, Meng Xia, Chengri Piao, Jianqin Zhang, Hikari Taka, Yoshiki Miura, Ayumu Sugiura, Soichiro Kakuta, Tadaharu Okazaki, Atsuyuki Yamataka, Go Miyano
{"title":"Hepatoprotective Effects of Imeglimin Are Associated With Preserved Mitochondrial Bioenergetics and Reduced Oxidative Stress in a Murine Cholestasis Model.","authors":"Hiroki Goto, Kazuto Suda, Takehiro Yasukawa, Takashi Fujimoto, Xuxuan Rao, Yosuke Tsunoda, Masataka Hida, Meng Xia, Chengri Piao, Jianqin Zhang, Hikari Taka, Yoshiki Miura, Ayumu Sugiura, Soichiro Kakuta, Tadaharu Okazaki, Atsuyuki Yamataka, Go Miyano","doi":"10.1111/hepr.70258","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Biliary atresia is a cholestatic liver disease that causes persistent inflammation and reduces the hepatic reserve. New therapeutic concepts are crucial to improve native liver survival. We investigated whether imeglimin, a mitochondria-targeting agent, has hepatoprotective effects on cholestatic liver disease using a murine bile duct ligation (BDL) model.</p><p><strong>Methods: </strong>BDL was performed in 4-5-week-old mice. After BDL, the mice received intraperitoneal imeglimin or vehicle injections. Sham-operated mice received vehicle. Blood and liver samples were collected on days 7 and 14 for biochemical and histological analysis. Mitochondrial morphology was examined by transmission electron microscopy. Quantitative PCR and immunoblotting were performed for inflammation and mitochondrial stress markers. Metabolomic profiling was conducted using capillary electrophoresis-mass spectrometry. Transcriptome was analyzed by RNA sequencing. Seahorse assays, ATP quantification, and MitoSOX staining were used to evaluate mitochondrial function and oxidative stress.</p><p><strong>Results: </strong>Imeglimin improved survival after BDL, and reduced serum AST, ALT, and bilirubin levels. Tissue fibrosis and Col1a1 and Acta2 expression were attenuated in imeglimin-treated livers. Glycolysis, amino acid metabolism, and mitochondrial electron transport activity were enhanced. Expression of genes associated with mitochondrial function, antioxidant defense, and metabolic regulation was upregulated. Mitochondrial morphology was preserved, and mitochondrial number and size increased. Imeglimin elevated oxygen consumption, extracellular acidification rates, and ATP levels of BDL mice livers, while reducing mitochondrial superoxide and oxidative protein modification by 4-hydroxynonenal. Expression levels of Il1β, Il6, and Tnf decreased.</p><p><strong>Conclusion: </strong>Imeglimin exerted hepatoprotective effects on BDL-operated mice, which are associated with preserved mitochondrial bioenergetic function and reduced oxidative stress.</p>","PeriodicalId":12987,"journal":{"name":"Hepatology Research","volume":" ","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2026-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hepatology Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/hepr.70258","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Biliary atresia is a cholestatic liver disease that causes persistent inflammation and reduces the hepatic reserve. New therapeutic concepts are crucial to improve native liver survival. We investigated whether imeglimin, a mitochondria-targeting agent, has hepatoprotective effects on cholestatic liver disease using a murine bile duct ligation (BDL) model.

Methods: BDL was performed in 4-5-week-old mice. After BDL, the mice received intraperitoneal imeglimin or vehicle injections. Sham-operated mice received vehicle. Blood and liver samples were collected on days 7 and 14 for biochemical and histological analysis. Mitochondrial morphology was examined by transmission electron microscopy. Quantitative PCR and immunoblotting were performed for inflammation and mitochondrial stress markers. Metabolomic profiling was conducted using capillary electrophoresis-mass spectrometry. Transcriptome was analyzed by RNA sequencing. Seahorse assays, ATP quantification, and MitoSOX staining were used to evaluate mitochondrial function and oxidative stress.

Results: Imeglimin improved survival after BDL, and reduced serum AST, ALT, and bilirubin levels. Tissue fibrosis and Col1a1 and Acta2 expression were attenuated in imeglimin-treated livers. Glycolysis, amino acid metabolism, and mitochondrial electron transport activity were enhanced. Expression of genes associated with mitochondrial function, antioxidant defense, and metabolic regulation was upregulated. Mitochondrial morphology was preserved, and mitochondrial number and size increased. Imeglimin elevated oxygen consumption, extracellular acidification rates, and ATP levels of BDL mice livers, while reducing mitochondrial superoxide and oxidative protein modification by 4-hydroxynonenal. Expression levels of Il1β, Il6, and Tnf decreased.

Conclusion: Imeglimin exerted hepatoprotective effects on BDL-operated mice, which are associated with preserved mitochondrial bioenergetic function and reduced oxidative stress.

在小鼠胆汁淤积模型中,伊米霉素的肝保护作用与线粒体生物能量的保存和氧化应激的降低有关。
目的:胆道闭锁是一种胆汁淤积性肝病,引起持续炎症并降低肝脏储备。新的治疗理念对提高原生肝脏存活率至关重要。我们利用小鼠胆管结扎(BDL)模型研究了线粒体靶向药物伊米霉素是否对胆汁淤积性肝病具有肝保护作用。方法:4 ~ 5周龄小鼠行BDL。BDL后,小鼠接受腹腔注射或载体注射。假手术小鼠接受载药。第7天和第14天采集血液和肝脏进行生化和组织学分析。透射电镜观察线粒体形态。对炎症和线粒体应激标志物进行定量PCR和免疫印迹检测。代谢组学分析采用毛细管电泳-质谱法。通过RNA测序分析转录组。海马实验、ATP定量和MitoSOX染色用于评估线粒体功能和氧化应激。结果:依米霉素提高了BDL患者的生存率,降低了血清AST、ALT和胆红素水平。组织纤维化和Col1a1和Acta2的表达在imeglimo处理的肝脏中减弱。糖酵解、氨基酸代谢和线粒体电子传递活性增强。与线粒体功能、抗氧化防御和代谢调节相关的基因表达上调。线粒体形态保持不变,线粒体数量和大小增加。伊米米明提高了BDL小鼠肝脏的耗氧量、细胞外酸化率和ATP水平,同时减少了线粒体超氧化物和4-羟基壬烯醛对氧化蛋白的修饰。il - 1β、il - 6、Tnf表达水平降低。结论:依米霉素对bdl手术小鼠具有保护肝脏的作用,其作用机制与维持线粒体生物能量功能和降低氧化应激有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Hepatology Research
Hepatology Research 医学-胃肠肝病学
CiteScore
8.30
自引率
14.30%
发文量
124
审稿时长
1 months
期刊介绍: Hepatology Research (formerly International Hepatology Communications) is the official journal of the Japan Society of Hepatology, and publishes original articles, reviews and short comunications dealing with hepatology. Reviews or mini-reviews are especially welcomed from those areas within hepatology undergoing rapid changes. Short communications should contain concise definitive information.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书